Flavokawain A suppresses the vasculogenic mimicry of HCC by inhibiting CXCL12 mediated EMT-Reference-Cited by-同舟云学术

Flavokawain A suppresses the vasculogenic mimicry of HCC by inhibiting CXCL12 mediated EMT

Published:2023-04 Issue: Volume:112 Page:154687
ISSN:0944-7113
Container-title:Phytomedicine
language:en
Short-container-title:Phytomedicine

Author:

Xiao Ting,Bao Jiali,Tian Jiao,Lin Rong,Zhang Zihui,Zhu Yuxin,He Yiming,Gao Dandi,Sun Ronghao,Zhang Fubo,Cheng Yexin,Shaletanati Jiadelati,Zhou Honggang,Xie Chunfeng,Yang Cheng

Publisher

Elsevier BV

Subject

Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine

Reference52 articles.

1. Flavokawain A Induces Apoptosis in MCF-7 and MDA-MB231 and Inhibits the Metastatic Process In Vitro;Abu;Plos One,2014

2. EMT in cancer;Brabletz;Nat Rev Cancer,2018

3. Neuroprotective racemic germacranolides from the roots of Chloranthus henryi;Chen;Fitoterapia,2020

4. Sesquiterpenoids with neuroprotective activities from the Chloranthaceae plant Chloranthus henryi;Chen;Fitoterapia,2021

5. A review on CXCR4/CXCL12 axis in oncology: No place to hide;Domanska;European Journal of Cancer,2013

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dihydroartemisinin inhibited vasculogenic mimicry in gastric cancer through the FGF2/FGFR1 signaling pathway;Phytomedicine;2024-11

2. Identification of new subtypes of breast cancer based on vasculogenic mimicry related genes and a new model for predicting the prognosis of breast cancer;Heliyon;2024-09

3. A rearranged abietane diterpenoid from Clerodendrum mandarinorum inhibits tumor progression of oral squamous cell carcinoma in vitro;Arabian Journal of Chemistry;2024-09

4. New perspectives on chemokines in hepatocellular carcinoma therapy: a critical pathway for natural products regulation of the tumor microenvironment;Frontiers in Immunology;2024-08-14

5. Resveratrol suppresses liver cancer progression by downregulating AKR1C3: targeting HCC with HSA nanomaterial as a carrier to enhance therapeutic efficacy;Apoptosis;2024-07-18